Catalog Number:
E45K53978M2-50Amount:
50 ugCite ID#:
EN5424068Price:
1223$Type:
Recombinant ProteinsResearch Field:
Serine Proteases and RegulatorsProtein length:
A DNA sequence encoding the cynomolgus DPP4 (XP_005573375.1) (Asp34-Pro766) was expressed with a polyhistidine tag at the C-terminus.Expression Host:
HEK293 CellsSpecies:
CynomolgusAmino acid sequence:
Asp34-Pro766Tag:
C-HisMolecular Weight:
The recombinant cynomolgus DPP4 consists 744 amino acids and predicts a molecular mass of 86 kDa.Activity:
At Leading Biology, the biological activity of a recombinant protein is routinely measured using a bioassay, e.g. chemotaxis or cell proliferation assay, enzyme assay, or a functional ELISA.Endotoxin:
< 1.0 EU per μg protein as determined by the LAL method.Gene Name:
dipeptidylpeptidase 4Gene symbol:
DPP4Protein Refseq:
XP_005573375.1Function:
CD Molecule proteins, Enzyme ProteinsSummary:
Dipeptidyl peptidase-4 (DPP4) or adenosine deaminase complexing protein 2 (ADCP 2) or T-cell activation antigen CD26 is a serine exopeptidase belonging to the S9B protein family that cleaves X-proline dipeptides from the N-terminus of polypeptides, such as chemokines, neuropeptides, and peptide hormones. The enzyme is a type II transmembrane glycoprotein, expressed on the surface of many cell types. It is also present in serum and other body fluids in a truncated form (sCD26/DPPIV). The soluble CD26 (sCD26) as a tumour marker for the detection of colorectal cancer (CRC) and advanced adenomas. As both a regulatory enzyme and a signalling factor, DPP4 has been evaluated and described in many studies. DPP4 inhibition results in increased blood concentration of the incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP). This causes an increase in glucose-dependent stimulation, resulting in a lowering of blood glucose levels. Recent studies have shown that DPP4 inhibitors can induce a significant reduction in glycosylated haemoglobin (HbA(1c)) levels, either as monotherapy or as a combination with other antidiabetic agents. Research has also demonstrated that DPP4 inhibitors portray a very low risk of hypoglycaemia development, and are a new pharmacological class of drugs for treating Type 2 diabetes.Form:
LyophilizedPurity:
> 95 % as determined by SDS-PAGE.Storage/Stability:
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.Storage Buffer:
Lyophilized from sterile PBS, pH 7.4.